Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients.

about

Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients.

Item

http://www.wikidata.org/entity/Q47152509

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Economic burden of preemptive ...... y of 208 consecutive patients.

@en

Economic burden of preemptive ...... y of 208 consecutive patients.

@nl

type

Item

label

Economic burden of preemptive ...... y of 208 consecutive patients.

@en

Economic burden of preemptive ...... y of 208 consecutive patients.

@nl

prefLabel

Economic burden of preemptive ...... y of 208 consecutive patients.

@en

Economic burden of preemptive ...... y of 208 consecutive patients.

@nl

P1476

Economic burden of preemptive ...... y of 208 consecutive patients.

@en

P2093

Andrea Toma

http://www.w3.org/2001/XMLSchema#string

Catherine Cordonnier

http://www.w3.org/2001/XMLSchema#string

Christel Dindorf

http://www.w3.org/2001/XMLSchema#string

Christine Robin

http://www.w3.org/2001/XMLSchema#string

Christophe Rodriguez

http://www.w3.org/2001/XMLSchema#string

Cécile Pautas

http://www.w3.org/2001/XMLSchema#string

Florence Beckerich

http://www.w3.org/2001/XMLSchema#string

François Hémery

http://www.w3.org/2001/XMLSchema#string

Isabelle Durand-Zaleski

http://www.w3.org/2001/XMLSchema#string

Julien Thillard

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions of cytomegalovirus infection and disease in transplant recipients

Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation.

Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial

Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimens

The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approaches.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses.

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy.

Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial

An international comparison of current strategies to prevent herpesvirus and fungal infections in hematopoietic cell transplant recipients.

P2888

s12879-017-2854-2

P304

747

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12879-017-2854-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1095860529

http://www.w3.org/2001/XMLSchema#string

P698

29207952

http://www.w3.org/2001/XMLSchema#string

P932

5717816

http://www.w3.org/2001/XMLSchema#string